C02.9
C02.9 — Malignant neoplasm of tongue, unspecified
Billable / specific codeICD-10-CM
C02.9 is a billable, specific ICD-10-CM code for malignant neoplasm of tongue, unspecified. It is valid for submission on a claim.
Risk adjustment
C02.9 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C02.9 is named in 44 Medicare coverage policies — 44 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C02. If C02.9 is not quite right, the correct code is usually one of these.
- C02.0Malignant neoplasm of dorsal surface of tongue
- C02.1Malignant neoplasm of border of tongue
- C02.2Malignant neoplasm of ventral surface of tongue
- C02.3Malignant neoplasm of anterior two-thirds of tongue, part unspecified
- C02.4Malignant neoplasm of lingual tonsil
- C02.8Malignant neoplasm of overlapping sites of tongue
Questions about C02.9
- Is C02.9 a billable ICD-10-CM code?
- Yes. C02.9 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C02.9 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lip, oral cavity and pharynx (C00-C14).